Character Biosciences · 3 months ago
VP, CMC & Technical Operations
Character Biosciences is a precision medicine company pioneering targeted therapies for polygenic diseases, focusing initially on ophthalmology. The VP of CMC & Technical Operations will lead all Chemistry, Manufacturing, and Controls activities, driving strategy and execution for early development and clinical supply.
Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareHealth DiagnosticsTherapeutics
Responsibilities
Serve as the company’s subject matter expert for CMC, providing guidance to development teams, executive leadership and the board
Define and implement CMC strategy across drug substance, drug product, and analytical sciences
Lead IND/IMPD CMC authoring and regulatory interactions
Develop and execute efficient and timely clinical supply chain
Collaborate with clinical operations to ensure CMC plans support rapid entry into first-in-human and proof-of-concept studies
Anticipate and mitigate manufacturing and supply risks in a resource-efficient way
Oversee CDMO selection and management for GMP manufacturing
Direct tech transfer of processes into external manufacturing sites
Ensure timely supply of clinical trial materials and stability testing
Collaborate with Quality to establish and maintain phase-appropriate quality systems
Ensure regulatory compliance with evolving clinical-stage requirements
Partner closely with clinical, regulatory, and nonclinical functions to align CMC deliverables with program timelines
Represent CMC/Operations at the executive level and with external stakeholders
Qualification
Required
Advanced degree (PhD, MS, or equivalent) in chemistry, biochemistry, engineering, or related field
12+ years of biopharma experience with strong expertise in biopharma CMC development including leadership roles in process development, manufacturing, and regulatory CMC
Proven track record of taking programs from early through late stage development and commercial launch
Successful track record supporting IND/IMPD submissions and early clinical trial supply
Hands-on experience with CDMO management and GMP manufacturing for clinical programs
Entrepreneurial, execution-focused mindset suitable for a lean biotech environment
Company
Character Biosciences
Character Biosciences is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
Funding
Current Stage
Growth StageTotal Funding
$137MKey Investors
Sanofi VenturesInnovation EndeavorsLifeforce Capital
2025-09-17Series B· $17M
2025-03-25Series B· $93M
2022-05-17Series A· $18M
Recent News
Longevity.Technology - Latest News, Opinions, Analysis and Research
2025-10-01
Longevity.Technology - Latest News, Opinions, Analysis and Research
2025-09-25
FierceBiotech
2025-09-23
Company data provided by crunchbase